TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
- 专利权人:
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 发明人:
- 申请号：
- IL21901412
- 公开号：
- IL219014D0
- 申请日:
- 2012.04.03
- 申请国别(地区):
- IL
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- TREATMENT OF GENOTYPIATED PATIENTS WITH DIABETES DPP-4 INHIBITORS SUCH AS LINAGLIPTIN
- TREATMENT OF GENOTYPED PATIENTS WITH DIABETES DPP-4 INHIBITORS, SUCH AS LINAGLIPTIN
- Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimers disease
- Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimers disease
- Composition for controlling plant diseases which comprises polyacetylenic acids or Prunella vulgaris L. extract containing them, and method for controlling plant diseases using the same
